CAR-T immune therapy attacks ovarian cancer in mice with a single dose
news.illinois.edu
A single dose of CAR-T immune therapy effectively held late-stage ovarian cancer at bay in mice for months, #ILLINOIS researchers demonstrated, showing the potential of CAR-T for difficult-to-treat solid tumors.